Skip to main content

Table 3 Risk of overweight and obesity and cardiovascular and metabolic syndrome risk factors in adult consumers and Non-consumers of tree nuts participating in the 2005–2010 National Health and Nutrition Examination Survey

From: Tree Nut consumption is associated with better adiposity measures and cardiovascular and metabolic syndrome health risk factors in U.S. Adults: NHANES 2005–2010

Variable

OR

LCL

UCL

Overweighta,b

1.02

0.67

1.24

Obesea,b

0.75*

0.60

0.95

Overweight or obesea,b

0.77*

0.62

0.95

WC elevateda,c

0.79*

0.64

0.99

Elevated systolic BPd

0.91

0.71

1.17

Elevated diastolic BPd

1.03

0.80

1.33

LDL-C elevatedd,e

0.80

0.57

1.14

HDL-C reducedd,e

0.85*

0.67

1.07

Triglycerides elevatedd,e

0.81

0.58

1.13

Glucose elevatedd,e

0.81

0.59

1.11

Insulin elevated (>85th Pctl)d

0.82

0.54

1.26

Metabolic syndromea,f

0.74

0.52

1.05

  1. Abbreviations: WC = Waist circumference, BP = Blood pressure, LDL-C = Low-density lipoprotein cholesterol, HDL-C = High-density lipoprotein cholesterol
  2. For Tree Nut Consumers, the reference group was no tree nut consumption
  3. aCovariates: Gender, Ethnicity, Age, Socioeconomic Status (PIR 0–1.25, 1.25-3.4,  ≥ 3.25), Physical Activity Level (sedentary, moderate, active), Current Smoker Status, and Alcohol
  4. bOveweight was defined as a BMI 25–29.9; obese was defined as a BMI ≥ 30; overweight or obese was defined as a BMI ≥25
  5. cElevated WC was defined as >102 cm (males), >88 cm (females)
  6. dCovariates: Gender, Ethnicity, Age, Socioeconomic Status (PIR 0–1.25, 1.25-3., ≥ 3.25), Physical Activity Level (sedentary, moderate, active), Current Smoker Status, Alcohol, and BMI
  7. eReduced HDL-cholesterol was defined as <40 mg/dL (males), <50 mg/dL (females); high triglycerides, ≥150 mg/dL or taking anti-hyperlipidemic medications; high fasting glucose, ≥110 mg/dL or taking insulin or other hypoglycemic agents. Elevated LDL-C ≥100 mg/dL
  8. fMetabolic syndrome was defined using the National Heart Lung and Blood Institute Adult Treatment Panel III criteria; that is having 3 or more of the following risk factors: abdominal obesity, WC > 102 cm (males), >88 cm (females); hypertension, SBP ≥130 mmHg or DBP ≥85 mmHg or taking anti-hypertensive medications; HDL-cholesterol, <40 mg/dL (males), <50 mg/dL (females); high triglycerides, ≥150 mg/dL or taking anti-hyperlipidemic medications; high fasting glucose, ≥110 mg/dL or taking insulin or other hypoglycemic agents
  9. *p < 0.05